HC Wainwright & Co. Initiates Coverage On Ensysce Biosciences With Buy Rating, Announces Price Target of $9
HC Wainwright & Co. Initiates Coverage On Ensysce Biosciences With Buy Rating, Announces Price Target of $9
HC Wainwright & Co.以買入評級啓動對Ensysce Biosciences的報道,宣佈目標股價爲9美元
HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Ensysce Biosciences (NASDAQ:ENSC) with a Buy rating and announces Price Target of $9.
HC Wainwright & Co. 分析師Raghuram Selvaraju啓動了對Ensysce Biosciences(納斯達克股票代碼:ENSC)的報道,評級爲買入,並宣佈目標股價爲9美元。